• Users Online: 206
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2022  |  Volume : 6  |  Issue : 4  |  Page : 494-500

Streptomyces sp. Vitnk9 derived compound against fish bacterial pathogens


Department of Biomedical Sciences, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India

Correspondence Address:
Kannabiran Krishnan
Department of Biomedical Sciences, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore - 632 014, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/bbrj.bbrj_296_22

Rights and Permissions

Background: The extensive research in the field of aquaculture is essential to combat the fish bacterial diseases causing massive economic loss to the aquaculture industry and these pathogens remains to be a threat to human well-being due to consumption of fish and fish products as a major food source. Methods: This study focuses on extraction and identification of the antibacterial compound produced by Streptomyces sp. VITNK9 against selected fish bacterial pathogens. Results: Bioactivity-guided extraction of ethyl acetate extract and purification results in isolation of the lead compound 1-(2-hydroperoxycyclopentyl)-4-hydroxytridecan-7-one (HCHD) from Streptomyces sp. VITNK9 having a chemical formula of C18H34O4 and a molecular weight of 314.46 g/mol. HCHD (100 μg/ml) demonstrated antibacterial activity with the inhibition zone of 19.33 ± 0.47 mm and the MIC (minimal inhibitory concentration) of 3.125 μg/ml toward Edwardsiella tarda and 16.66 ± 0.47 mm and the MIC value of 12.5 μg/ml against Aeromonas hydrophila. In silico molecular docking studies showed the interaction of HCHD with the drug target enzyme acetate kinase of E. tarda and A. hydrophila. It showed the least binding free energy of-6.5Kcal/mol and-6.1 Kcal/mol with acetate kinase of E. tarda and A. hydrophila, respectively. Conclusion: The outcome of this study suggests that the inhibition of bacterial acetate kinase by the lead compound HCHD and thereby affects the bacterial metabolism. Streptomyces species are more promising source for isolating antibacterial secondary metabolites for controlling fish bacterial pathogens.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed424    
    Printed14    
    Emailed0    
    PDF Downloaded45    
    Comments [Add]    

Recommend this journal